Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs OlleveCare
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · OlleveCare: Check date not recorded
vs
Verdict39/ 100
Grade C · #548OlleveCare
OlleveCare is a small virtual-urgent-care storefront that has added a cash-pay weight-management track using compounded semaglutide and tirzepatide, available across 13 listed states (including DC).
Visit OlleveCareThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 39/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. OlleveCare still earns its place — shoppers who want one-stop virtual care pairing GLP-1 with urgent care and refills.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results44
92
Real-world results44
97Price honesty20
97
Price honesty20
96Prescriber access36
96
Prescriber access36
88Formulary choice40
88
Formulary choice40
95Cancellation fairness56
95
Cancellation fairness56
93Member support44
93
Member support44
Price, coverage & features
| Metric | CoreAge Rx | OlleveCare |
|---|---|---|
| Verdict Score | 94/100 | 39/100 |
| Grade | A | C |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | Not disclosed |
| Coverage | All 50 states | 13 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
OlleveCare
What we like
- 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
- Both semaglutide and tirzepatide offered — switch molecules without switching platforms
- Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
- Cash-pay with a superbill option for out-of-network reimbursement
- Founder Ahmed Emam is named in the footer
The caveats
- Legal entity name not disclosed anywhere — can't be verified in a state registry
- Pricing not shown before booking — you must enter the intake flow to see the fee
- Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
- No medical director or prescribing clinician named — only 'board-certified providers'
- No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers who want one-stop virtual care pairing GLP-1 with urgent care and refills.
Visit OlleveCare Read the full OlleveCare review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for OlleveCare does the reverse.
More on CoreAge Rx
More on OlleveCare
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.